Systematic analysis of Fc mutations designed to enhance binding to Fc-gamma receptors.

Abstract excerpt

A critical attribute of therapeutic antibodies is their ability to engage with humoral or cellular effector mechanisms, and this depends on the ability of the Fc region to bind to complement (C1q) or Fc receptors. Investigators have sought to optimize these effects by engineering the Fc region to bind to a greater or lesser extent to individual receptors. Different approaches have been used in the clinic, but...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antibodies, Monoclonal
• Share to Antibody-Dependent Cell Cytotoxicity
• Share to Immunoglobulin Fc Fragments